The future of the RTS,S/AS01 malaria vaccine: an alternative development plan

RTS,S/AS01 is the falciparum malaria vaccine candidate that is most advanced in development, globally.<br/> In a large clinical trial in sub-Saharan African children, the protection conferred by RTS,S/AS01 was found to rapidly decline, particularly in infants. <br/>Although RTS,S/AS01 wa...

Täydet tiedot

Bibliografiset tiedot
Päätekijät: Gosling, R, von Seidlein, L
Aineistotyyppi: Journal article
Kieli:English
Julkaistu: Public Library of Science 2015
_version_ 1826291122857574400
author Gosling, R
von Seidlein, L
author_facet Gosling, R
von Seidlein, L
author_sort Gosling, R
collection OXFORD
description RTS,S/AS01 is the falciparum malaria vaccine candidate that is most advanced in development, globally.<br/> In a large clinical trial in sub-Saharan African children, the protection conferred by RTS,S/AS01 was found to rapidly decline, particularly in infants. <br/>Although RTS,S/AS01 was approved by the European Medicines Agency for active immunization of children aged 6 weeks to 17 months against malaria, the WHO did not recommend the inclusion of RTS,S/AS01 in the Expanded Programme of Immunisations (EPI). <br/>Instead of aiming for inclusion of the vaccine in EPI, we propose that the future development of RTS,S/AS01 could take advantage of its high transient protective efficacy. <br/>Adding the vaccine to intensive malaria elimination strategies in low-endemicity areas could be the critical factor in interrupting transmission.
first_indexed 2024-03-07T02:54:40Z
format Journal article
id oxford-uuid:aedbf19a-1e67-4104-a26f-8c0f003f23be
institution University of Oxford
language English
last_indexed 2024-03-07T02:54:40Z
publishDate 2015
publisher Public Library of Science
record_format dspace
spelling oxford-uuid:aedbf19a-1e67-4104-a26f-8c0f003f23be2022-03-27T03:45:37ZThe future of the RTS,S/AS01 malaria vaccine: an alternative development planJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:aedbf19a-1e67-4104-a26f-8c0f003f23beEnglishSymplectic Elements at OxfordPublic Library of Science2015Gosling, Rvon Seidlein, LRTS,S/AS01 is the falciparum malaria vaccine candidate that is most advanced in development, globally.<br/> In a large clinical trial in sub-Saharan African children, the protection conferred by RTS,S/AS01 was found to rapidly decline, particularly in infants. <br/>Although RTS,S/AS01 was approved by the European Medicines Agency for active immunization of children aged 6 weeks to 17 months against malaria, the WHO did not recommend the inclusion of RTS,S/AS01 in the Expanded Programme of Immunisations (EPI). <br/>Instead of aiming for inclusion of the vaccine in EPI, we propose that the future development of RTS,S/AS01 could take advantage of its high transient protective efficacy. <br/>Adding the vaccine to intensive malaria elimination strategies in low-endemicity areas could be the critical factor in interrupting transmission.
spellingShingle Gosling, R
von Seidlein, L
The future of the RTS,S/AS01 malaria vaccine: an alternative development plan
title The future of the RTS,S/AS01 malaria vaccine: an alternative development plan
title_full The future of the RTS,S/AS01 malaria vaccine: an alternative development plan
title_fullStr The future of the RTS,S/AS01 malaria vaccine: an alternative development plan
title_full_unstemmed The future of the RTS,S/AS01 malaria vaccine: an alternative development plan
title_short The future of the RTS,S/AS01 malaria vaccine: an alternative development plan
title_sort future of the rts s as01 malaria vaccine an alternative development plan
work_keys_str_mv AT goslingr thefutureofthertssas01malariavaccineanalternativedevelopmentplan
AT vonseidleinl thefutureofthertssas01malariavaccineanalternativedevelopmentplan
AT goslingr futureofthertssas01malariavaccineanalternativedevelopmentplan
AT vonseidleinl futureofthertssas01malariavaccineanalternativedevelopmentplan